ARCHIVES

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

This article is from The Cancer Letter archive.

Vol. 22 No. 34 | September 6, 1996

Download PDF Visit The Full Archive

Related Articles

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998